Advanced in Osteosarcoma

Monika Csoka

7-9. Tűzoltó Str, 
Budapest, BU, HU 
Advanced in Osteosarcoma
7-9. Tűzoltó Str, 
Budapest, BU, HU 
OverviewLocationsClinical Research

Overview

Monika Csoka practices in Budapest, Hungary. Ms. Csoka is rated as an Advanced expert by MediFind in the treatment of Osteosarcoma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Osteosarcoma, Rhabdomyosarcoma, and Acute Lymphoblastic Leukemia (ALL).

Her clinical research consists of co-authoring 58 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles and participated in 1 clinical trial in the study of Osteosarcoma.

Gender
Female

Locations

7-9. Tűzoltó Str, Budapest, BU 1094, Hungary

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-Label, Multicenter, Phase I/II Clinical Trial to Identify the Modufolin® Dose With Most Favorable Safety Prospect and Confirmed Ability to Mitigate High-Dose Methotrexate Induced Toxicity During Treatment of Osteosarcoma Patients
An Open-Label, Multicenter, Phase I/II Clinical Trial to Identify the Modufolin® Dose With Most Favorable Safety Prospect and Confirmed Ability to Mitigate High-Dose Methotrexate Induced Toxicity During Treatment of Osteosarcoma Patients
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Intergroup Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase III Trial
Intergroup Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Evaluation of Rituximab Efficacy and Safety in High Risk Patients - Phase III Trial
Enrollment Status: Unknown
Publish Date: June 14, 2017
Intervention Type: Drug
Study Drugs: Vincristine, Cyclophosphamide, Methotrexate, Doxorubicin, Cytarabine, Ara-C, Rituximab
Study Phase: Phase 3
View 1 Less Clinical Trial

58 Total Publications

The role of molecular pathology in the diagnosis, prognosis, and management of childhood tumors
The role of molecular pathology in the diagnosis, prognosis, and management of childhood tumors
Journal: Orvosi hetilap
Published: August 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Csoka's expertise for a condition
ConditionClose
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile